Hazard ratios for survival in 101 patients from AML17 with dual Flt3L measurement and MRD assessment after course 1
| . | HR . | 95% CI . | Test . | P . |
|---|---|---|---|---|
| EFS | ||||
| Flt3L <291 vs ≥291 | 0.51 | 0.31-0.84 | Log rank | .0076 |
| MRD positive vs negative | 0.38 | 0.23-0.61 | Log rank | .0001 |
| Flt3L <291 vs ≥291, adjusting for MRD | 0.57 | 0.32-1.03 | Cox | .0600 |
| OS | ||||
| Flt3L <1185 vs ≥1185 | 0.38 | 0.18-0.79 | Log rank | .0097 |
| MRD positive vs negative | 0.41 | 0.23-0.73 | Log rank | .0025 |
| Flt3L <1185 vs ≥1185, adjusting for MRD | 0.25 | 0.06-1.05 | Cox | .0590 |
| . | HR . | 95% CI . | Test . | P . |
|---|---|---|---|---|
| EFS | ||||
| Flt3L <291 vs ≥291 | 0.51 | 0.31-0.84 | Log rank | .0076 |
| MRD positive vs negative | 0.38 | 0.23-0.61 | Log rank | .0001 |
| Flt3L <291 vs ≥291, adjusting for MRD | 0.57 | 0.32-1.03 | Cox | .0600 |
| OS | ||||
| Flt3L <1185 vs ≥1185 | 0.38 | 0.18-0.79 | Log rank | .0097 |
| MRD positive vs negative | 0.41 | 0.23-0.73 | Log rank | .0025 |
| Flt3L <1185 vs ≥1185, adjusting for MRD | 0.25 | 0.06-1.05 | Cox | .0590 |
HR, hazard ratio; CI, confidence interval.